We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current OMER market cap is 412.25M. The company's latest EPS is USD -2.7007 and P/E is -2.71.
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -39.77M | -39.03M | -59.16M | -35.41M | -35.66M |
| Net Income | -9.07M | -37.18M | -56.04M | -32.23M | -31.36M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 73.81M | 0 | 0 | 0 | 0 |
| Operating Income | -110.6M | -173.62M | -163.39M | -164.53M | -169.26M |
| Net Income | -138.06M | 194.24M | 47.42M | -117.81M | -156.82M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 378.27M | 437.49M | 356.31M | 313.34M | 277.08M |
| Total Liabilities | 403.25M | 508.82M | 480.91M | 467.51M | 459.69M |
| Total Equity | -24.98M | -71.33M | -124.6M | -154.17M | -182.61M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 181.04M | 419.27M | 590.97M | 378.27M | 277.08M |
| Total Liabilities | 301.79M | 395.49M | 505.29M | 403.25M | 459.69M |
| Total Equity | -120.75M | 23.78M | 85.68M | -24.98M | -182.61M |
| Quarter End | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 74.73M | -41.78M | -87.77M | -119.82M | -148.8M |
| Investing | 27.45M | -61.93M | 11.23M | 47.26M | 82.22M |
| Financing | -106.08M | 98.43M | 71.56M | 66.98M | 62.88M |
| Year End 31 December 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -100.09M | -109.72M | -86.48M | 74.73M | -148.8M |
| Investing | -67.03M | 193.71M | -127.56M | 27.45M | 82.22M |
| Financing | 174.53M | 6.32M | 124.25M | -106.08M | 62.88M |
| Market Cap | 412.25M |
| Price to Earnings Ratio | -2.71 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 124.74 |
| Price to Book Ratio | -2.32 |
| Dividend Yield | - |
| Shares Outstanding | 58.06M |
| Average Volume (1 week) | 527.57k |
| Average Volume (1 Month) | 931.06k |
| 52 Week Change | 135.88% |
| 52 Week High | 13.60 |
| 52 Week Low | 2.965 |
| Spread (Intraday) | 1.05 (13.04%) |
| Company Name | Omeros Corporation |
| Address |
3400 capitol blvd se tumwater, washington 98501 |
| Website | https://www.omeros.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
